CBX4 and osteosarcoma: It has been proposed that CBX4 is retained in the cytoplasm through interaction with the glutamate metabotropic receptor 4 (GRM4), which then blocks nuclear CBX4‐mediated gene regulation, proliferation, migration, and invasion ability of osteosarcoma cells [103].